Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 406517
                    [Title] => Filipinos still don't have full access to cheaper medicines
                    [Summary] => Filipinos still do not have full access to cheaper medicines as the implementing rules and regulations (IRR) crafted by ...
                    [DatePublished] => 2008-10-12 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 1480108
                    [AuthorName] => Ma. Elisa Osorio 
                    [SectionName] => Business
                    [SectionUrl] => business
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 370723
                    [Title] => Gov’t scraps plan to import hypertension drug Norvasc
                    [Summary] => 



The Philippine International Trading Corp. (PITC) will not import the hypertension drug Norvasc now that local pharmaceutical manufacturer United Laboratories Inc. (Unilab) has come out with its own cheaper hypertension drug, Amvasc.


According to PITC chairman and president Roberto M. Pagdanganan, Unilab’s Amvasc will retail at P17.50 compared to Pfizer’s P74.75 for the 10 milligram tablet and P44.75 for the five mg tablet.


PITC is being sued by Pfizer for patent infringement for importing 40 tablets of Norvasc.


                    [DatePublished] => 2006-11-23 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 1805266
                    [AuthorName] => Marianne V. Go
                    [SectionName] => Business
                    [SectionUrl] => business
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 196087
                    [Title] => Roxas bucks WTO proposal on manufacture of drugs
                    [Summary] => Trade and Industry Secretary Manuel Roxas II said yesterday the Philippines is against  a recent proposal of the World Trade Organization (WTO) to limit the coverage of compulsory licensing to locally manufacture imported pharmaceuticals only to cases of national emergencies and other situation of extreme urgency.


"If the proposal is adopted, it would effectively douse cold water on our program of providing affordable medicines especially to the poor," Roxas said.


                    [DatePublished] => 2003-02-20 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Business
                    [SectionUrl] => business
                    [URL] => 
                )

            [3] => Array
                (
                    [ArticleID] => 192312
                    [Title] => RP at odds with EU over issue of pharmaceutical licensing
                    [Summary] => The Philippines is at odds with the European Union (EU) over the issue of compulsory licensing to manufacture vital pharmaceutical products now being negotiated at the World Trade Organization (WTO).


The Philippines, along with other developing countries, is insisting on the Doha Declaration reached in 2001 which allowed compulsory licensing under the Trade Related Aspects of Intellectual Property Rights (TRIPS) Agreement.


Normally, only licensed pharmaceutical firms are allowed to manufacture certain medicines,  making them expensive and not readily available to all.

                    [DatePublished] => 2003-01-21 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Business
                    [SectionUrl] => business
                    [URL] => 
                )

            [4] => Array
                (
                    [ArticleID] => 153938
                    [Title] => RP finds ally in effort to push tuna exports to Europe
                    [Summary] => The Philippines has found an ally in its dispute with the European Union over the country’s tuna exports, which are being subjected to higher tariffs compared to competitors from other Pacific Island nations.


Agriculture Secretary Leonardo Q. Monetayor said Risto Volanen, the secretary general of the Committee on Agricultural Cooperation in the EU who is in town for the two-day 4th Asian Farmers Group for Cooperation (AFGC) meeting in Ortigas vowed to help the Philippines with its tuna trade problems in the European market.


                    [DatePublished] => 2002-03-15 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 1720791
                    [AuthorName] => Rose de la Cruz
                    [SectionName] => Business
                    [SectionUrl] => business
                    [URL] => 
                )

        )

)

DOHA DECLARATION

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 406517
                    [Title] => Filipinos still don't have full access to cheaper medicines
                    [Summary] => Filipinos still do not have full access to cheaper medicines as the implementing rules and regulations (IRR) crafted by ...
                    [DatePublished] => 2008-10-12 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 1480108
                    [AuthorName] => Ma. Elisa Osorio 
                    [SectionName] => Business
                    [SectionUrl] => business
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 370723
                    [Title] => Gov’t scraps plan to import hypertension drug Norvasc
                    [Summary] => 



The Philippine International Trading Corp. (PITC) will not import the hypertension drug Norvasc now that local pharmaceutical manufacturer United Laboratories Inc. (Unilab) has come out with its own cheaper hypertension drug, Amvasc.


According to PITC chairman and president Roberto M. Pagdanganan, Unilab’s Amvasc will retail at P17.50 compared to Pfizer’s P74.75 for the 10 milligram tablet and P44.75 for the five mg tablet.


PITC is being sued by Pfizer for patent infringement for importing 40 tablets of Norvasc.


                    [DatePublished] => 2006-11-23 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 1805266
                    [AuthorName] => Marianne V. Go
                    [SectionName] => Business
                    [SectionUrl] => business
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 196087
                    [Title] => Roxas bucks WTO proposal on manufacture of drugs
                    [Summary] => Trade and Industry Secretary Manuel Roxas II said yesterday the Philippines is against  a recent proposal of the World Trade Organization (WTO) to limit the coverage of compulsory licensing to locally manufacture imported pharmaceuticals only to cases of national emergencies and other situation of extreme urgency.


"If the proposal is adopted, it would effectively douse cold water on our program of providing affordable medicines especially to the poor," Roxas said.


                    [DatePublished] => 2003-02-20 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Business
                    [SectionUrl] => business
                    [URL] => 
                )

            [3] => Array
                (
                    [ArticleID] => 192312
                    [Title] => RP at odds with EU over issue of pharmaceutical licensing
                    [Summary] => The Philippines is at odds with the European Union (EU) over the issue of compulsory licensing to manufacture vital pharmaceutical products now being negotiated at the World Trade Organization (WTO).


The Philippines, along with other developing countries, is insisting on the Doha Declaration reached in 2001 which allowed compulsory licensing under the Trade Related Aspects of Intellectual Property Rights (TRIPS) Agreement.


Normally, only licensed pharmaceutical firms are allowed to manufacture certain medicines,  making them expensive and not readily available to all.

                    [DatePublished] => 2003-01-21 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Business
                    [SectionUrl] => business
                    [URL] => 
                )

            [4] => Array
                (
                    [ArticleID] => 153938
                    [Title] => RP finds ally in effort to push tuna exports to Europe
                    [Summary] => The Philippines has found an ally in its dispute with the European Union over the country’s tuna exports, which are being subjected to higher tariffs compared to competitors from other Pacific Island nations.


Agriculture Secretary Leonardo Q. Monetayor said Risto Volanen, the secretary general of the Committee on Agricultural Cooperation in the EU who is in town for the two-day 4th Asian Farmers Group for Cooperation (AFGC) meeting in Ortigas vowed to help the Philippines with its tuna trade problems in the European market.


                    [DatePublished] => 2002-03-15 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 1720791
                    [AuthorName] => Rose de la Cruz
                    [SectionName] => Business
                    [SectionUrl] => business
                    [URL] => 
                )

        )

)

abtest

Filipinos still don't have full access to cheaper medicines

By Ma. Elisa Osorio  | October 12, 2008 - 12:00am

Filipinos still do not have full access to cheaper medicines as the implementing rules and regulations (IRR) crafted by ...

Business

Gov’t scraps plan to import hypertension drug Norvasc

By Marianne V. Go | November 23, 2006 - 12:00am

The Philippine International Trading Corp. (PITC) will not import the hypertension drug Norvasc now that local pharmaceutical manufacturer United Laboratories Inc. (Unilab) has come out with its own cheaper...

Business

Roxas bucks WTO proposal on manufacture of drugs

February 20, 2003 - 12:00am

Trade and Industry Secretary Manuel Roxas II said yesterday the Philippines is against a recent proposal of the World Trade Organization (WTO) to limit the coverage of compulsory licensing to locally manufacture...

Business

RP at odds with EU over issue of pharmaceutical licensing

January 21, 2003 - 12:00am

The Philippines is at odds with the European Union (EU) over the issue of compulsory licensing to manufacture vital pharmaceutical products now being negotiated at the World Trade Organization (WTO). The Philippines,...

Business

RP finds ally in effort to push tuna exports to Europe

By Rose de la Cruz | March 15, 2002 - 12:00am

The Philippines has found an ally in its dispute with the European Union over the country’s tuna exports, which are being subjected to higher tariffs compared to competitors from other Pacific Island nations. Agriculture...

Business